Trust Company’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1
| Closed | -$90 | – | 968 |
|
|
2026
Q1 | $90 | Hold |
1
| – | – | ﹤0.01% | 890 |
|
|
2025
Q4 | $90 | Buy |
+1
| New | +$95 | ﹤0.01% | 873 |
|
|
2024
Q2 | – | Sell |
-4
| Closed | -$528 | – | 358 |
|
|
2024
Q1 | $528 | Hold |
4
| – | – | ﹤0.01% | 333 |
|
|
2023
Q4 | $487 | Hold |
4
| – | – | ﹤0.01% | 301 |
|
|
2023
Q3 | $449 | Buy |
+4
| New | +$508 | ﹤0.01% | 311 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$12.9K | – | 332 |
|
|
2023
Q1 | $12.9K | Hold |
100
| – | – | ﹤0.01% | 250 |
|
|
2022
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 243 |
|
|
2022
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 256 |
|
|
2022
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 261 |
|
|
2022
Q1 | $13K | Sell |
100
-3
| -3% | -$362 | ﹤0.01% | 270 |
|
|
2021
Q4 | $13K | Hold |
103
| – | – | ﹤0.01% | 250 |
|
|
2021
Q3 | $15K | Hold |
103
| – | – | ﹤0.01% | 240 |
|
|
2021
Q2 | $16K | Hold |
103
| – | – | 0.01% | 239 |
|
|
2021
Q1 | $16K | Hold |
103
| – | – | 0.01% | 245 |
|
|
2020
Q4 | $15K | Hold |
103
| – | – | 0.01% | 222 |
|
|
2020
Q3 | $14K | Hold |
103
| – | – | 0.01% | 241 |
|
|
2020
Q2 | $12K | Hold |
103
| – | – | 0.01% | 235 |
|
|
2020
Q1 | $10K | Hold |
103
| – | – | 0.01% | 227 |
|
|
2019
Q4 | $15K | Hold |
103
| – | – | 0.01% | 225 |
|
|
2019
Q3 | $14K | Hold |
103
| – | – | 0.01% | 238 |
|
|
2019
Q2 | $12K | Hold |
103
| – | – | 0.01% | 240 |
|
|
2019
Q1 | $13K | Sell |
103
-103
| -50% | -$11.7K | 0.01% | 267 |
|
|
2018
Q4 | $21K | Hold |
206
| – | – | 0.01% | 209 |
|
|
2018
Q3 | $26K | Buy |
206
+103
| +100% | +$12.2K | 0.01% | 207 |
|
|
2018
Q2 | $11K | Hold |
103
| – | – | 0.01% | 271 |
|
|
2018
Q1 | $11K | Hold |
103
| – | – | ﹤0.01% | 274 |
|
|
2017
Q4 | $12K | Hold |
103
| – | – | 0.01% | 273 |
|
|
2017
Q3 | $12K | Hold |
103
| – | – | 0.01% | 237 |
|
|
2017
Q2 | $13K | Hold |
103
| – | – | 0.01% | 250 |
|
|
2017
Q1 | $12K | Hold |
103
| – | – | 0.01% | 278 |
|
|
2016
Q4 | $10K | Hold |
103
| – | – | 0.01% | 295 |
|
|
2016
Q3 | $13K | Hold |
103
| – | – | 0.01% | 284 |
|
|
2016
Q2 | $12K | Hold |
103
| – | – | ﹤0.01% | 276 |
|
|
2016
Q1 | $11K | Hold |
103
| – | – | 0.01% | 274 |
|
|
2015
Q4 | $10.3K | Sell |
103
-759
| -88% | -$74.3K | ﹤0.01% | 276 |
|
|
2015
Q3 | $79K | Hold |
862
| – | – | 0.04% | 136 |
|
|
2015
Q2 | $91K | Hold |
862
| – | – | 0.06% | 152 |
|
|
2015
Q1 | $98K | Buy |
+862
| New | +$98.3K | 0.06% | 122 |
|
Other funds holding ZBH
DLA
WAM
QAM
NCM
SFA
GHAM
CNB
Trust Company's ZBH Position: Q2 2026 in Review
Trust Company sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 1 share — an estimated $90 sold.
Trust Company first reported a position in ZBH in Q1 2015 and held it in 38 quarters. The position peaked at $98K in Q1 2015. 113 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Trust Company reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
- Trust Company sold 1 Zimmer Biomet share in Q2 2026, an estimated $90.
- Trust Company first reported a position in Zimmer Biomet in Q1 2015 and held it in 38 quarters.
- Trust Company's Zimmer Biomet position peaked at $98K in Q1 2015.
- 113 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.